Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 6/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.62 |
| ▸ | MAPT | P10636 | 5/20 | 0.62 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.62 |
| ▸ | HPGD | P15428 | 2/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.62 |
| ▸ | LMNA | P02545 | 2/20 | 0.62 |
| ▸ | TP53 | P04637 | 2/20 | 0.62 |
| ▸ | USP2 | O75604 | 1/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.62 |
| ▸ | MAOA | P21397 | 4/20 | 0.56 |
| ▸ | CYP1B1 | Q16678 | 3/20 | 0.54 |
| ▸ | AR | P10275 | 3/20 | 0.54 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.54 |
| ▸ | FTO | Q9C0B1 | 2/20 | 0.54 |
| ▸ | PKM | P14618 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31344371 | 1.00 | MEN1 (0.62) | MEN1KMT2ACYP3A4MAPTALOX15 | |
| SCHEMBL15955977 | 0.89 | AR (0.55) | MEN1KMT2ACYP3A4MAPTALOX15 | |
| SCHEMBL27586284 | 0.86 | MAOA (0.47) | MEN1KMT2ACYP3A4MAPTALOX15 | |
| SCHEMBL31398712 | 0.84 | MAPT (0.44) | MEN1KMT2ACYP3A4MAPTALOX15 | |
| SCHEMBL11356163 | 0.83 | MEN1 (0.55) | MEN1KMT2ACYP3A4MAPTALOX15 | |
| SCHEMBL571525 | 0.82 | NTRK1 (0.52) | MEN1KMT2ACYP3A4MAPTMAPK1 | |
| SCHEMBL27586405 | 0.82 | AR (0.62) | MEN1KMT2ACYP3A4MAPTALOX15 | |
| SCHEMBL1255490 | 0.82 | MEN1 (0.48) | MEN1KMT2ACYP3A4MAPTALOX15 | |
| SCHEMBL28278290 | 0.80 | ALDH1A1 (0.60) | MEN1KMT2ACYP3A4MAPTALOX15 | |
| SCHEMBL30495370 | 0.80 | HDAC4 (0.54) | MEN1KMT2ACYP3A4MAPTALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 474 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114642241-B | Composite plant polyphenol chelate and application method thereof | 武汉轻工大学 | 2024-01-26 | — | — | CN | claimed |
| CN-114642241-A | Composite plant polyphenol chelate and using method thereof | 武汉轻工大学 | 2022-06-21 | — | — | CN | claimed |
| CN-111606881-B | Synthesis method of 3',4',5',6,7, 8-hexahydroxy isoflavone and application thereof in antioxidation | 中国人民解放军联勤保障部队第九〇四医院 | 2022-03-11 | — | — | CN | claimed |
| CN-113512018-A | Flavonoid compound and preparation method and application thereof | 合肥工业大学 | 2021-10-19 | — | — | CN | claimed |
| CN-214020732-U | Preparation facilities of 4, 7 dihydroxy isoflavone | 四川新一美生物科技有限公司 | 2021-08-24 | — | — | CN | claimed |
| CN-112205530-A | Antibiotic-free feed for improving production performance of weaned piglets and preparation method thereof | 广东省农业科学院动物科学研究所 | 2021-01-12 | — | — | CN | claimed |
| CN-111620918-A | 8-beta-D-glucopyranose-4', 7-dihydroxyisoflavone FAM derivative and synthetic method thereof | 辽宁中医药大学 | 2020-09-04 | — | — | CN | claimed |
| CN-111606881-A | Synthesis method of 3 ', 4 ', 5 ', 6, 7, 8-hexahydroxy isoflavone and application thereof in antioxidation | 中国人民解放军联勤保障部队第九〇四医院 | 2020-09-01 | — | — | CN | claimed |
| CN-111317732-A | Pharmaceutical composition for preventing nephropathy of CT contrast agent and preparation method thereof | 牡丹江医学院 | 2020-06-23 | — | — | CN | claimed |
| CN-110250394-A | A kind of feed composite antioxidant and preparation method thereof | 广东省农业科学院动物科学研究所 | 2019-09-20 | — | — | CN | claimed |
| CN-1582920-A | Oral disintegrants of daidzein for treating cardio-vagal blood vessels diseases and their preparation | XU XUDONG (CN) | 2005-02-23 | — | — | CN | claimed |
| US-20040259181-A1 | detecting beta-D-ribofuranosidase activity using novel chromogenic beta-D-ribofuranoside substrates such as catechol-beta-D-ribofuranoside or 3',4'-dihydroxyflavone-4'-beta-D-dibofuranoside; kits | BURTON MICHAEL (GB) | 2004-12-23 | — | — | US | claimed |
| US-20040209825-A1 | Inhibition by 3-deoxyflavonoids of T-lymphocyte activation and therapies related thereto | LAHEY THOMAS P (US) | 2004-10-21 | — | — | US | claimed |
| CN-1528286-A | Soybean aglycone drop pill and preparing method thereof | 南昌弘益科技有限公司 | 2004-09-15 | — | — | CN | claimed |
| US-6774142-B2 | MAY BE ADMINISTERED ALONG WITH RUTIN, A RUTIN CONGENER AND/OR A RUTIN DERIVATIVE. | IMMUNOBIOTICS, INC. | 2004-08-10 | — | — | US | claimed |
| EP-1438424-A2 | ENZYME SUBSTRATES FOR DETECTING BETA-D-RIBOFURANOSIDASE ACTIVITY | Burton, Michael (GB) | 2004-07-21 | — | — | EP | claimed |
| WO-2003035897-A2 | ENZYME SUBSTRATES FOR DETECTING BETA-D-RIBOFURANOSIDASE ACTIVITY | BURTON MICHAEL (GB) | 2003-05-01 | — | — | WO | claimed |
| CN-1306434-A | Composition for preventing and/or treating osteoporosis and pathologies resulting from menopausal syndrome | SIGMA TAU HEALTHSCIENCE SPA (IT) | 2001-08-01 | — | — | CN | claimed |
| CN-1259130-A | Preparation of isoflavones from leguminous plants | NOVOGEN INC (US) | 2000-07-05 | — | — | CN | claimed |
| WO-1998021946-A1 | COMPOSITION AND TREATMENT FOR PERSISTENT REPRODUCTIVE TRANSITION SYMPTOMS | INTERNUTRIA, INC. (US) | 1998-05-28 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040209825-A1 | Inhibition by 3-deoxyflavonoids of T-lymphocyte activation and therapies related thereto | HLA-DRB1, NFATC1, CD4 | MEN1 4047/4885KMT2A 3519/4885CYP3A4 105/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.